Integra LifeSciences has higher revenue and earnings than PetVivo. Integra LifeSciences is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

1 Day IART 0.65% DJIA 1.39% S&P Mid Cap 400 0.99% Health Care/Life Sciences -0.37% ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Integra Lifesciences (IART – Research Report). The company’s shares closed yesterday at $24.72.

Good day. Thank you for standing by. Welcome to Integra LifeSciences Fourth Quarter 2024 Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded. I ...

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.39% this morning, while Treasury yields also slipped amid worries that U.S. President ...

For the quarter ended December 2024, Integra LifeSciences (IART) reported revenue of $442.65 million, up 11.5% over the same period last year. EPS came in at $0.97, compared to $0.89 in the year ...

In a report released today, Ryan Zimmerman from BTIG maintained a Hold rating on Integra Lifesciences (IART – Research Report). The company’s shares opened today at $21.50. See what stocks are ...